Abstract
To the Editor: The review article by Feinberg (April 5 issue)1 about the key role of epigenetics in human disease prevention and mitigation does not mention intrauterine growth restriction as an example of modulation of epigenetic information by the environment. In the early 1990s, Barker speculated about a possible correlation between low weight at birth and an increased risk of disease later in life.2 Since then, an extensive amount of scientific evidence3 has confirmed an existing causal relationship between the perturbations of fetal growth and the onset of the metabolic syndrome,2 a condition characterized by hypertension and insulin resistance. Intrauterine . . .